Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biological properties of pneumolysin

T J Mitchell1, P W Andrew

  • 1Division of Infection and Immunity, University of Glasgow, Scotland.

Microbial Drug Resistance (Larchmont, N.Y.)
|April 1, 1997
PubMed
Summary

Pneumolysin is a harmful protein released by the bacteria Streptococcus pneumoniae. This toxin helps the bacteria cause disease by damaging host cells and disrupting the immune system. Researchers have used modified versions of this toxin to understand how it contributes to bacterial infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Vision Changes to Hospice: The Rapid Progression of Orbital Metastasis in Hepatocellular Carcinoma.

Cureus·2025
Same author

Case of Early Pregnancy.

Atlanta medical and surgical journal (1884)·2022
Same author

Microvesicles released from pneumolysin-stimulated lung epithelial cells carry mitochondrial cargo and suppress neutrophil oxidative burst.

Scientific reports·2021
Same author

Author Correction: Phase variation in pneumococcal populations during carriage in the human nasopharynx.

Scientific reports·2020
Same author

Phase variation in pneumococcal populations during carriage in the human nasopharynx.

Scientific reports·2020
Same author

Molecular analysis of virulence factors of Streptococcus pneumoniae.

Journal of applied microbiology·2017

Area of Science:

  • Microbiology and infectious disease research involving pneumolysin
  • Pathogenesis studies within immunology

Background:

Streptococcus pneumoniae remains a major global pathogen responsible for significant morbidity and mortality. Scientists have long recognized that this bacterium secretes various proteins to facilitate colonization and tissue invasion. Pneumolysin represents a primary virulence factor, yet its precise mechanisms of host cell interaction require further clarification. Prior research has shown that this protein belongs to the cholesterol-dependent cytolysin family. That uncertainty drove investigations into how the toxin interacts with host membranes. No prior work had resolved the specific contributions of its diverse biological activities to overall disease progression. This gap motivated detailed studies using purified toxins and genetic variants. Understanding these interactions provides a foundation for developing future therapeutic interventions against pneumococcal infections.

Purpose Of The Study:

The aim of this study is to define the contribution of various biological activities of pneumolysin to bacterial virulence. Researchers sought to resolve how this multifunctional toxin interacts with host systems to promote infection. The investigation addresses the specific problem of identifying which toxin properties are most relevant for disease progression. This work was motivated by the need to understand the complex interactions between the pathogen and the host immune system. No prior work had fully mapped the diverse functions of this protein to its pathogenic outcomes in animal models. The authors intended to clarify the role of membrane damage versus immune interference. By using purified toxins and genetic variants, the team aimed to isolate individual functional components. This research provides a structured analysis of how the toxin facilitates the survival of the pneumococcus.

Keywords:
Streptococcus pneumoniaecytolysinbacterial infectionimmune evasion

Frequently Asked Questions

The researchers propose that pneumolysin facilitates virulence through two primary mechanisms: the direct lysis of eukaryotic cell membranes and the active interference with soluble immune system components. This dual-action approach allows the pathogen to evade host defenses while simultaneously damaging surrounding tissue.

Scientists utilize purified native toxin, mutant toxin variants, and isogenic mutants of Streptococcus pneumoniae. These tools allow for the systematic comparison between wild-type bacterial strains and those expressing altered versions of the protein to isolate specific functional contributions.

The authors indicate that the toxin is a thiol-activated, membrane-damaging protein. This specific chemical property is necessary for the toxin to successfully bind and disrupt the integrity of host cell membranes during the infection process.

Related Experiment Videos

Main Methods:

Review Approach involved evaluating data derived from purified native and mutant toxin preparations. Investigators examined the specific biological impacts of these proteins on eukaryotic cell integrity. The team utilized isogenic bacterial strains to compare wild-type and modified toxin expressions. This design allowed for the isolation of individual functional activities within the host environment. Researchers assessed how these variations influenced the overall pathogenic potential of the bacteria. The approach prioritized the correlation between structural protein changes and observable host damage. Data synthesis focused on distinguishing between membrane-damaging effects and immune system interference. This systematic evaluation provided a comprehensive overview of the toxin's role in infection models.

Main Results:

Key Findings From the Literature demonstrate that pneumolysin acts as a potent membrane-damaging agent. The toxin exhibits a broad range of biological activities that directly facilitate bacterial survival. Results show that the protein effectively lyses eukaryotic cells, thereby compromising host tissue barriers. The literature confirms that the toxin interferes with both cellular and soluble components of the immune system. Studies using isogenic mutants reveal that these combined activities are essential for full virulence. The data indicate that the protein's multifunctional nature is a critical aspect of its pathogenic profile. Observations in animal models consistently link the presence of the toxin to increased disease severity. These findings establish a clear connection between the toxin's diverse functions and its overall impact on the host.

Conclusions:

Synthesis and Implications suggest that pneumolysin acts as a versatile tool for bacterial survival within the host. The authors propose that its ability to damage eukaryotic membranes directly facilitates tissue destruction. Evidence indicates that the toxin also modulates immune responses by interfering with soluble molecules. Researchers conclude that the multifunctional nature of this protein is a key driver of bacterial virulence. The use of isogenic mutants has successfully mapped specific activities to pathogenic outcomes. These findings clarify how structural variations in the toxin influence its overall toxic potential. The study confirms that the protein is not merely a pore-forming agent but a complex immune modulator. Future efforts should focus on targeting these specific biological functions to mitigate disease severity.

The researchers utilize isogenic mutants to determine the role of specific toxin versions. By comparing strains that express altered proteins against those with native versions, they can pinpoint how individual functional changes impact the overall ability of the bacteria to cause disease.

The study measures the biological activity of the toxin, specifically its capacity to lyse eukaryotic cells. This phenomenon is compared against the toxin's ability to disrupt immune system function, highlighting the broad range of effects the protein exerts on the host.

The authors claim that the multifunctional nature of pneumolysin is a significant factor in pneumococcal virulence. They suggest that defining these diverse activities provides a clearer understanding of how the pathogen successfully establishes infection within animal models.